The authors found that trimethylamine N-oxide (TMAO) binds to PERK at physiologically relevant concentrations and selectively activates the PERK mediated induction of the transcription factor FoxO1, a key driver of metabolic disease. This evidence concerns the gene EIF2AK3 and metabolic disease.